References
- MacGregor RR, Sheagren JN, Lipsett MB, et al. Alternate-day prednisone therapy: evaluation of delayed hypersensitivity responses, control of disease and steroid side effects. N Engl J Med 1969: 280(Jun 26): 1427 31
- Fauci AS, Dale DC. Alternate-day prednisone therapy and human lymphocyte subpopulations. J Clin Invest 1975: 55(1): 22–32
- Nichols T. Nugent CA, Tyler FH. Diurnal variation in suppression of adrenal function by glucocorticoids. J Clin Endocrinol Metab 1965: 25(Mar): 343–9
- Salaman JR. Steroids and modern immunosuppression. Br Med J 1983: 286(1): 1373–5
- Fauci AS, Dale DC, Balow JE. Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med 1976: 84(3): 304–15
- Hess EV, Kammen PL. Pulse therapy in rheumatoid arthritis. Ann Intern Med 1981: 94(1): 128–9
- Ayoub WT, Hale RC, Harrington TM, et al. Adverse effects of Intravenous methylprednisone pulse therapy (PT) in systemic lupus erythematosus. (Abstr) Arthritis Rheum 1983: 26(4): S34
- Fauci AS, Haynes BF. Katz P, et al. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983: 98(1): 76–85
- Fauci AS, Haynes BF, Katz P. The spectrum of vasculitis: clinical, pathologic, immunologic, and therapeutic considerations. Ann Intern Med 1978: 89(5 Pt 1): 660–76
- Katz P. Immunosuppressant therapy. Adv Intern Med (in press)
- Michaels RM. Nashel DJ. Leonard A, et al. Weekly intravenous methotrexate in the treatment of rheumatoid arthritis. Arthritis Rheum 1982: 25(3): 339–41